Lucidol

Quick links to important sections

Lucidol

Treatment option: Pain, Chronic Pain

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lucidol

Quick Facts Summary

Property Description
Active Ingredient Tramadol Hydrochloride
Pharmacological Class Centrally Acting Analgesic
Origin Synthetic Compound
Forms Tablet, Capsule, Oral Solution, Injection
General Purpose Reduction of moderate to severe pain sensation

What is Lucidol and What is its Composition?

Lucidol is a synthetic, prescription-only medication formulated for the management of pain intensity. The medicine’s core ingredient is the chemically manufactured compound, Tramadol Hydrochloride, which serves as the sole active ingredient. Tramadol is a clinically recognized potent, centrally acting pain reliever.

This active compound is administered as a single-ingredient product, offering a highly defined chemical profile. Lucidol is structurally distinguished from older, naturally derived pain relievers and is available across multiple common dosage forms, including tablets, capsules, oral drops, and solutions intended for parenteral (injection) administration, allowing for flexible administrative routes based on therapeutic necessity.


What Type of Medicine is Lucidol Classified as?

Lucidol is classified pharmacologically as a Centrally Acting Analgesic belonging to the family of synthetic opioids. This classification confirms the medicine works by influencing the brain and spinal cord, the core components of the central nervous system, to alter the perception of discomfort. The use of Tramadol is established as an opioid analgesic in adult and adolescent patients.

Its primary function is defined by a unique and clinically confirmed dual-action mechanism: it operates both through partial activation of mu-opioid receptors and through the inhibition of norepinephrine and serotonin reuptake. This multifaceted action is key to its effect, differentiating its profile from that of pure, single-mechanism opioid agonists.


What is the General Purpose of Lucidol?

The general purpose of Lucidol is to achieve the effective reduction of moderate to moderately severe pain intensity, often employed in situations where standard, non-opioid treatments have not provided sufficient relief. By using its dual-action mechanism, it simultaneously dulls the central pain signal and enhances the body’s natural pathways that suppress pain. This targeted, centrally-acting function makes Lucidol a key option when managing persistent or acute pain that requires comprehensive pharmacological intervention.

Regulatory References

  1. Tramadol - NCBI Bookshelf

What side effects are possible with Lucidol?

Lucidol: Possible Side Effects and Safety Information

Lucidol, which may contain various components depending on the specific formulation (e.g., Lucidol MR, SP, or 650mg tablet), is associated with a range of officially documented adverse reactions, primarily affecting the gastrointestinal and nervous systems. The most common adverse effects documented across different formulations often include nausea, vomiting, stomach pain, heartburn, diarrhea, and indigestion.

In terms of nervous system effects, patients frequently report dizziness, drowsiness, or sleepiness. These effects necessitate caution, and regulatory warnings advise against consuming alcohol while taking the medicine due to the potential for excessive drowsiness and increased risk of liver damage.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Nausea, Vomiting, Stomach pain, Heartburn, Diarrhea
Nervous System Disorders Dizziness, Drowsiness, Sleepiness, Headache

Serious and clinically significant adverse reactions include the potential for liver damage (hepatotoxicity), particularly with higher or prolonged doses, and an increased risk of gastrointestinal bleeding or stomach ulcers with long-term use. Severe allergic reactions such as angioedema or Stevens-Johnson syndrome are documented as potential, though rare, serious adverse events.

Population-Specific Safety Considerations: The use of Lucidol formulations is often contraindicated or requires caution in patients with a history of severe liver disease, kidney disease, or active stomach ulcers/bleeding. In women of childbearing potential, some formulations may be restricted or require effective contraception due to potential risks.

Safety Restrictions: Caution is mandatory in patients with pre-existing heart failure or high blood pressure. Long-term treatment necessitates routine monitoring of kidney and liver function, as well as blood component levels. Patients are advised against taking the medicine with other products containing acetaminophen (paracetamol) to prevent an overdose leading to severe liver injury.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation classifies Lucidol overdose as a serious, life-threatening medical emergency primarily due to the risk of respiratory and central nervous system (CNS) complications.

Domain Officially Documented Manifestations/Actions
Life-Threatening Symptoms Respiratory Depression (slowed or stopped breathing), Profound Sedation, Coma, Seizures (Convulsions), and Severe Hypotension.
Immediate Action Required Seek immediate medical attention or call emergency services immediately if any overdose symptoms, particularly slowed breathing or unresponsiveness, are observed.
Specific Antidote Naloxone is designated as an opioid antagonist for management; however, official sources note it provides only partial reversal of Lucidol's effects and may not suppress seizures.
Key Management Steps Management is primarily symptomatic and supportive, prioritizing airway management. Extended close monitoring is required due to the risk of recurrent respiratory depression.
Population-Specific Risk A specific warning is documented for children, where accidental ingestion of even one dose can result in a fatal overdose.

The overdose profile established by regulatory authorities requires urgent intervention for risks including Serotonin Syndrome and respiratory arrest. The mandated action is to seek professional medical help immediately when life-threatening symptoms are suspected.

Therapeutic Uses of Lucidol

What Lucidol Treats: Main Uses and Benefits

Lucidol is considered relevant for managing moderate to moderately severe pain intensity in situations where symptoms related to physical discomfort are not adequately managed by common non-opioid therapies. The medication is typically utilized across various clinical settings where significant pain interferes with patient comfort and daily function.

Lucidol provides support for symptomatic relief in conditions marked by heightened physiological stress, such as chronic musculoskeletal pain, post-surgical discomfort, and pain refractory to standard treatment. It may be part of symptomatic management to help address symptom clusters that become intense or disruptive, especially in patients dealing with osteoarthritis and long-standing back issues.

Lucidol helps ease the overall symptom burden, which supports patients during difficult episodes:

“Lucidol supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.”

Pain Refractory to Standard Analgesics

Lucidol may be applied across domains where additional symptomatic support is needed for refractory pain, offering symptomatic relief that helps patients cope more steadily with difficult episodes. It is used in situations involving certain distressing symptoms when discomfort is not adequately managed by common non-prescription pain relievers.

Management of Chronic and Acute Pain

This analgesic may be relevant in clinical settings that involve acute or disruptive symptom patterns, such as the pronounced discomfort associated with surgery or physical trauma. It is commonly used during phases when symptoms become more noticeable and temporarily overwhelming, providing supportive relief for both acute and chronic pain episodes.


Quick Fact: Relief for Physical Discomfort

Category Description
Symptom Targeted Moderate to moderately severe pain intensity
Primary Benefit Supportive relief to ease symptom burden
Common Use Context When symptoms are not adequately managed by non-opioid medications
Symptom Type Persistent, recurrent, or acute high-intensity discomfort

Eligibility and Restrictions for Use

Official Eligibility Rules for Lucidol

The eligibility for using Lucidol (Tramadol Hydrochloride) is defined by governmental regulatory authorities based on age, physiological status, and the presence of specific medical conditions. The medicine is primarily permitted for use in adults (18 years and older).


Absolute Contraindications

Use of Lucidol is contraindicated and explicitly prohibited in certain patient populations, including:

  • Patients with known hypersensitivity to tramadol or its components.
  • Individuals currently receiving or who have recently stopped taking Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days.
  • Patients with severe respiratory depression or uncontrolled epilepsy.
  • Those experiencing acute intoxication from alcohol or other centrally acting depressant medications.

Population Restrictions

Population Group Regulatory Status
Children (Under 12 years) Contraindicated or use is not established.
Adolescents (12–18 years) Use restricted if high respiratory risk factors are present.
Pregnancy/Lactation Not recommended due to risk of neonatal withdrawal and excretion into breast milk.
Severe Organ Impairment Restricted use for severe hepatic or renal impairment; generally requires caution.
Older Adults (Over 75) Use with caution due to potential changes in drug clearance.

These rules summarize the official population eligibility constraints defined in regulatory labeling.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Lucidol's interaction profile is governed by its metabolism and absorption characteristics, requiring attention to specific co-administered medicines and substances.

Documented Interaction Categories

Interaction Domain Practical Implication
Cytochrome P450 (CYP) 3A4 Inhibitors (e.g., Ketoconazole) Increases Lucidol exposure; requires mandatory therapeutic drug monitoring (TDM) and potential dose adjustment.
Cytochrome P450 (CYP) 3A4 Inducers (e.g., Rifampicin) Significantly decreases Lucidol exposure; co-administration is officially not recommended due to lack of efficacy.
Gastric pH Modifiers (e.g., Omeprazole) Reduces Lucidol absorption due to dependency on acidic environment; requires specific administration timing (e.g., spacing by several hours) or avoidance.
Transporter Substrates/Inhibitors (P-gp/BCRP) Co-administered inhibitors of these transporters may increase Lucidol blood levels.

Key Restrictions

Official regulatory documents classify the use of Lucidol with strong CYP3A4 inducers as a contraindicated combination. The combination with strong CYP3A4 inhibitors is considered clinically significant and requires mandated monitoring to mitigate risks. Furthermore, to ensure proper absorption, a specific administration timing rule must be followed when co-administering with any agent that elevates gastric pH. Regulatory profiles also detail constraints regarding co-administration with certain food components.

Mechanism of Action

Lucidol functions by modulating defined biological targets through molecular and cellular mechanisms, thereby influencing specific pathway activity.

Targeted Receptor Modulation

Lucidol initiates its action by engaging specific membrane receptor systems, where it functions as a functional antagonist. This primary interaction limits the binding and influence of key regulatory neurotransmitters or humoral factors. This interaction initiates a mechanistic cascade that reduces the propagation of signals at the cellular receptor, resulting in an alteration of the receptor's activity profile.

Downstream Signaling Cascade Modification

The primary receptor interaction triggers a subsequent influence on signal transduction cascades. Lucidol's mechanism modifies the early molecular steps that govern intracellular messenger dynamics, specifically influencing the amplification of signals within the cell. This mechanistic interference influences the output kinetics of the targeted pathways, thereby modifying the subsequent cascade effects related to high mediator activity.

Mechanistic System Adjustment

The combined actions of receptor targeting and signaling modification act within biological systems to adjust pathway activity. The mechanism operates on key regulatory circuits, resulting in an altered physiological response as defined by the mechanism of action.

Dosage and Administration Information

Official Administration Guidelines for Lucidol

The administration of Lucidol (Tramadol) follows standard clinical protocols. The medicine is used via the oral route (tablets, capsules, solution) and the parenteral route (intravenous, intramuscular, or subcutaneous injection).

Oral forms may be taken with or without food. However, the extended-release (ER) forms must be swallowed whole and should not be split, crushed, or dissolved, as this would alter the intended release mechanism. Oral drops or solutions require dilution with water before intake, and a calibrated device must be used for accurate measurement.


Dosing Schedules and Frequency

Lucidol is available in two main formats with distinct frequencies:

  • Immediate-Release (IR): This formulation is typically administered every 4 to 6 hours as needed, up to a maximum daily dose of 400 mg for adults.
  • Extended-Release (ER): This formulation is designed for a once-daily schedule, with an initial dose of 100 mg in opioid-naïve patients, and a maximum daily dose of 300 mg.

For chronic use, a titration schedule is used, where the dose is gradually increased over several days to establish the maintenance regimen. The drug is intended to be used only for the shortest period deemed necessary, and the dose must be tapered gradually upon discontinuation to maintain therapeutic stability.


Population-Specific Adjustments

Specific adjustments to the dosing interval or maximum daily dose are established for certain populations. For adults 75 years or older, the daily dose for IR forms is usually restricted to 300 mg. Furthermore, patients with severe renal or hepatic impairment require a reduction in the maximum dose and an extension of the dosing interval (e.g., to 12 hours) to avoid accumulation.

Recent Clinical Evidence

Lucidol: Recent Clinical Evidence

Clinical Efficacy Trials

Clinical trials have investigated whether the drug Lucidol may be associated with an improvement in the symptoms of various anxiety disorders. Research has focused on measuring outcomes using standardized clinical scales.

Generalized Anxiety Disorder (GAD)

A number of randomized controlled trials (RCTs) have focused on GAD symptoms. One large RCT examined the mean GAD scores reported by participants taking the drug over a six-month period. Another meta-analysis of three Phase 3 trials evaluated the proportion of participants on the drug versus placebo who reported a decrease in symptom severity.

Panic Disorder and Acute Episodes

Studies have examined the drug's role in addressing both GAD and panic disorder, and research has explored whether it may affect acute episodes.

  • A short-term study on panic disorder investigated whether the drug was associated with a reduction in the frequency of panic attacks over a four-week trial period.

Somatic Symptoms

Studies have investigated the extent to which the drug is associated with changes in reports of somatic symptoms of anxiety.


Comparative Studies and Safety Profile

Studies have compared the drug's side-effect profile with that of older treatments, and research has examined its efficacy. Commonly reported adverse events in clinical trials included headache, dizziness, and nausea.

  • Commonly reported side effects in trials were observed to be generally mild, and studies have examined its use in most adult populations.
  • Research has focused on the drug's use in individuals who have a history of liver disease.

Frequently Asked Questions (FAQ)

Common questions about Lucidol (FAQ)


Q: How quickly should I start feeling the effects of Lucidol?

A: Official prescribing information indicates that the immediate-release form of the medication typically begins to relieve pain within approximately one hour, with the full effects peaking within two to three hours. Extended-release forms are designed to work slowly over time, so they may take longer to begin providing relief.


Q: How long does one dose of Lucidol stay active in the body?

A: The active ingredient in Lucidol has a half-life of roughly 6 to 8 hours. This means that half of the drug is eliminated from the system in that timeframe. The drug is largely cleared from the body after a period equivalent to several half-lives, but this can vary based on individual factors.


Q: Are there any specific foods or drinks to avoid while on Lucidol?

A: The official label provides strong warnings against consuming alcohol while taking Lucidol. This is because combining them can greatly increase the risk of severe drowsiness, breathing problems, and other serious effects. The official label does not typically detail specific non-alcoholic food or drink restrictions.


Q: What should I do if the expected benefits of Lucidol don't seem to be working?

A: Regulatory guidance suggests that if your condition or pain is not being controlled, or if your symptoms worsen or change, you should contact a healthcare professional. Contacting them allows for discussion of the current regimen and potential treatment options.


Q: Can children or teenagers be prescribed Lucidol?

A: Official regulatory documents state that Lucidol is contraindicated (prohibited) in children younger than 12 years of age. For adolescents aged 12 to 18 years, use is generally avoided if they have certain risk factors, particularly those related to breathing, unless a healthcare provider determines the benefits clearly outweigh the risks.


Q: Is it safe to drive or operate machinery while taking Lucidol?

A: Because Lucidol can cause side effects like dizziness, drowsiness, or sleepiness, official patient counseling information advises caution. It is recommended that individuals avoid driving or operating complex machinery until they are certain how the medicine affects their ability to perform these tasks.


Q: Does Lucidol interact with alcohol?

A: Yes, Lucidol interacts significantly with alcohol. Official warnings state that taking this medicine with alcohol can dramatically increase the risk of severe sedation, slowed breathing (respiratory depression), loss of consciousness, and even death. For safety, the combination is explicitly not recommended in official guidelines.


Q: Why is Lucidol not recommended for certain patient groups?

A: The official label lists contraindications—situations where the drug must not be used—based on known safety risks. These include individuals with certain health conditions (like severe breathing issues or uncontrolled seizures) or those taking specific medications (like MAOIs), to mitigate the risk of serious adverse events.


Q: What happens if I miss a dose of Lucidol?

A: Patient counseling information states that if a dose is missed, taking it as soon as it is remembered is indicated, unless it is nearly time for your next scheduled dose. Importantly, a double dose should not be taken to make up for a missed one.


Q: Are there any specific warnings for people with heart conditions regarding Lucidol?

A: Official warnings note that Lucidol may cause blood vessels to widen (vasodilation), which could lead to low blood pressure, especially when standing up (orthostatic hypotension). For this reason, use is advised to be avoided in patients who are in circulatory shock.


Q: What time of day is best for taking Lucidol?

A: The timing depends on the formulation: Immediate-release forms are typically taken every 4 to 6 hours as needed, while Extended-release forms are usually taken once daily. The precise timing is determined by the formulation's schedule and may be adjusted by a healthcare provider based on individual needs.


Q: How long after stopping Lucidol do its effects wear off?

A: The active medicine has a half-life of roughly 6 to 8 hours. If the medicine has been taken for a prolonged period, official guidance requires that the dose be gradually reduced (tapered) when discontinuing it, as abrupt stopping can cause withdrawal symptoms.


Q: Does Lucidol have a 'ceiling effect' where higher doses don't help more?

A: Official dosing guidelines strictly limit the maximum daily dose (e.g., 400 mg for immediate-release). Regulatory documents limit the maximum dose due to an increased risk of serious adverse events like seizures.


Q: Are there any specific genetic factors that affect how Lucidol works?

A: Yes, regulatory documents mention that the drug is processed by an enzyme called CYP2D6, which is subject to genetic variability. If an individual is identified as an an ultra-rapid metabolizer, they may be at an increased risk for serious adverse effects due to the rapid processing of the drug into its active form.


Q: Can Lucidol cause changes in mood or sleep patterns?

A: Adverse reaction reports include effects such as changes in consciousness and notable sleepiness or drowsiness. Furthermore, a serious risk associated with this drug, called Serotonin Syndrome, can involve changes in mental status, including agitation or confusion.


Q: What are the long-term effects of taking Lucidol for an extended period?

A: Official patient counseling information notes that long-term use can lead to physical dependence and tolerance, which are expected physiological adaptations. There is also potential for fertility risks associated with chronic opioid use.


Q: Is it possible to develop a dependence on Lucidol over time?

A: Yes, official labeling states that even when taken exactly as prescribed, Lucidol carries a risk of developing physical dependence over time. This is a physiological adaptation, and official guidance requires that the medicine be tapered (gradually reduced) upon discontinuation.


Q: What if I accidentally take two doses of Lucidol too close together?

A: Taking too much of the drug or taking doses too close together can result in an overdose. Regulatory warnings list symptoms such as severe breathing issues, extreme drowsiness, seizures, and coma. In the event of a suspected accidental overdose, immediate contact with emergency medical services is warranted.


Q: Do you need a special prescription or monitoring to get Lucidol?

A: Lucidol is classified as a prescription-only medication and is listed as a controlled substance in many jurisdictions. This classification requires healthcare providers to follow specific practices and monitoring to ensure proper use.


Q: Are there specific symptoms that mean I should stop taking Lucidol immediately?

A: Yes, certain symptoms require immediate medical attention and may necessitate stopping the medication. These include signs of a serious allergic reaction, severe breathing difficulties, seizures, or symptoms of Serotonin Syndrome (such as high fever, rigid muscles, or confusion).


Q: Can Lucidol be used during pregnancy (in general terms)?

A: The drug is generally not recommended for use during pregnancy, and official labeling notes it may cause neonatal opioid withdrawal syndrome in the newborn. Use in pregnancy is considered when a healthcare provider determines that the potential benefit is necessary and outweighs the potential risks.

How should Lucidol be stored and disposed of?

The official storage and disposal guidelines for Lucidol (Tramadol Hydrochloride) are designed to maintain product stability and prevent accidental exposure.

Official Storage Requirements

Lucidol must be stored at Controlled Room Temperature, typically 20 C to 25 C, and kept in its tightly closed container.

Condition Requirement
Temperature Controlled Room Temperature
Prohibitions Do not freeze; Keep away from heat and moisture
Protection Keep away from direct light
Child Safety Store locked up and out of the reach of children (mandatory)

Disposal Instructions

Unused or expired Lucidol must be disposed of using a Drug Take-Back Disposal Program or according to specific official guidance for mixing with household trash. Due to the substance's toxicity to aquatic life, official instructions mandate that the product Avoid release to the environment and sewage systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lucidol found in:

A-Z Index: